Fang Moore
3Patents
0h-index
9Co-inventors
27Inventor score
Filing activity: Jun 10, 2015 → Mar 25, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11639353B2 | Cyclobutanes- and azetidine-containing mono and spirocyclic compounds as αV integrin inhibitors | Human Necessities | 0 | Active |
| US9974778B2 | Substituted pyridinones as MGAT2 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11014922B2 | Cyclobutane- and azetidine-containing mono and spirocyclic compounds as αV integrin inhibitors | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.